StockData
Iambic Therapeutics, Inc. logo

Iambic Therapeutics, Inc. (IAM) fundamentals chart

IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$14.76+0.54 (+3.80%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Fundamental chart

No history to chart yet

This company has fewer than two fiscal years of reported financials.

See a number that looks wrong?